Selecta Biosciences
World Rank (Jan-05-2024)
19,733
Market Cap (Jan-05-2024)
0.140 Billion USD
World Rank (Jul-30-2023)
19,120
Market Cap (Jul-30-2023)
0.164 Billion USD
World Rank (Dec-25-2022)
19,583
Market Cap (Dec-25-2022)
0.150 Billion USD
World Rank (Jan-07-2022)
15,851
Market Cap (Jan-07-2022)
0.34 Billion USD
Annual Revenue in USD
17 Million USD
Annual Net Income in USD
-69 Million USD
Annual Results for Period Ending
Dec-2020 ending year
Company Profile
Selecta Biosciences is a Biopharmaceutical and Gene Therapy company wholly owned, proprietary pipeline and work with partners with the goal of addressing immunogenicity to create life changing therapies for patients and their families. The company annual revenue is 27.6 million USD and 39 employees as on 2019. The headquarters is in USA.
Company Website